The streptozotocin (STZ)-induced diabetes in a rat model is a T cell-mediated autoimmune disease associated with a marked decrease in insulin levels [4], exhibiting metabolic characteristics similar to those of type 1 diabetes in humans [5]. The gene discussed is INS; the disease is autoimmune disease.